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Abstract 
Background: Bronchial asthma is a heterogeneous respiratory condition which can be mimicked by a wide range 
of pathologies including upper airways stenosis. The accurate diagnosis of asthma, as with other conditions, may be 
influenced by fixation errors, which are common in medicine and occur when a physician concentrates on only one 
element of a clinical case without considering other relevant aspects. Here we report a challenging case characterized 
by the contemporaneous presence of a common disease, asthma, together with a rare respiratory disease, idiopathic 
tracheal stenosis.
Case presentation: The 56-year-old female patient, a former smoker, was referred to our outpatient clinic for exer-
tional dyspnea and persistent wheezing. There were no other respiratory or systemic symptoms over the past three 
months, and a psychological component was suspected. Spirometry with flow-volume evaluation and bronchos-
copy were the key elements to establish the diagnoses and provide treatments. Once the diagnosis of asthma was 
confirmed, the combination of the anti-inflammatory corticosteroid fluticasone and the rapid-acting bronchodilator 
formoterol in a single inhaler effectively controlled the patient’s symptoms, confirming the favorable efficacy and 
safety profile which are reflected in the recommendations of the international guidelines.
Conclusions: In this paper we describe the clinical investigations and interventions that eventually confirmed a 
diagnosis of asthma complicated by an idiopathic tracheal stenosis and led to effective treatment of the patient. 
Awareness of fixation error may avoid misdiagnosis in patients with respiratory disease and a complicated history at 
presentation.
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Background
Bronchial asthma is a heterogeneous, chronic condition 
affecting at least 4% of the worldwide population [1]. It 
is characterized by respiratory symptoms such as dysp-
nea, cough, and wheezing, often increasing at night and 
with exercise. The distinctive features of the disease are 
airway hyper-responsiveness to a variety of stimuli, air-
way inflammation, and remodeling [2]. Despite a growing 
number of studies, the precise pathogenesis of asthma 
still remains unclear. The diagnosis relies on the clini-
cal suspicion supported by either the spirometric detec-
tion of an obstructive ventilatory defect reversible after 
administration of a β2-agonist, or the evidence of a vari-
ation in lung function greater than in healthy individuals 
[3, 4]. Symptoms and spirometric values may vary widely 
spontaneously or with therapy and, on average, disease 
control is achievable in most patients. Inhalation drugs 
represent the first therapeutic option and include varia-
ble doses of corticosteroids ± β2-agonist bronchodilators 
according to the severity of the disease [3]. A wide range 
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of pathologies, including upper airway stenosis and vocal 
cord dysfunction, may mimic bronchial asthma [5, 6].
Case presentation
A 56-year-old female patient, a former smoker with a his-
tory of 5 pack/years, was referred to our outpatient clinic 
for dyspnea and wheezing. Her medical history consisted 
of elective cholecystectomy 5 years before, a small renal 
cyst on sonographic follow-up, and systemic hyperten-
sion well controlled by angiotensin II receptor blockers. 
Her mother was affected by systemic hypertension and 
asthma. The patient had no history of allergies or res-
piratory disease. The patient complained of wheezing, 
present both during inspiration and expiration, and exer-
tional dyspnea while climbing stairs, without other res-
piratory or systemic symptoms over the past 3 months.
Due to worsening of the symptoms the patient presented 
to the Emergency Department, where clinical parameters 
were stable (oxygen saturation [SpO2] of 98%) and a chest 
X-ray showed no infiltrates, nor pleural effusion. She was 
discharged with a diagnosis of “anxiety”. In the follow-
ing month her general practitioner, with the suspicion of 
asthma, empirically treated her with inhaled beclometha-
sone 100 mcg b.i.d. Due to a lack of improvement an 
electrocardiogram and echocardiogram were performed, 
which were normal, and she was subsequently sent for res-
piratory consultation to confirm the diagnosis of asthma. 
At our respiratory service the patient was eupneic at rest, 
with normal clinical parameters while breathing room air 
and well nourished (body mass index 25.0 kg/m2). Physi-
cal examination showed inspiratory stridor during forced 
inspiration. Spirometry was performed according to the 
ERS/ATS guidelines and showed a repeatable plateau of 
both the inspiratory and expiratory maneuvers, suggestive 
of fixed central or upper airway obstruction [4]. Forced-
expiratory volume in one second (FEV1) was 2.03 L (83% of 
the predicted value), forced vital capacity (FVC) was 2.89 
L (101% of the predicted value) and FEV1/FVC ratio was 
0.70, 89% of the predicted value (Fig. 1).
The patient was further evaluated with flexible 
bronchoscopy, which confirmed a subglottic tracheal 
stenosis extended for 15  mm with an internal diam-
eter of 6 mm (Fig. 2). Autoimmunity testing was nega-
tive. The patient underwent rigid bronchoscopy with 
mucosal biopsies, mechanical dilatation laser-assisted 
(diode laser) and balloon to correct the stenosis, which 
reached an internal diameter of 13 mm after the proce-
dure (Fig.  3). Biopsies showed non-specific fibro-scle-
rosis with no signs of vasculitis or cancer. Immediately 
after treatment, symptoms improved, while spirometry 
performed seven days after the procedure showed a 
normal flow volume loop with normalized obstructive 
indexes: FEV1 of 2.76 L, FVC of 3.05 L, and FEV1/FVC 
ratio of 0.91 (respectively, 114, 107, and 115% of the 
predicted values).
During follow-up at 2 and 5  months the patient pre-
sented relapses of the tracheal stenosis, due to which the 
endoscopic treatment was repeated with success. Seven 
months after the bronchoscopic treatment the patient 
complained of paroxysmal dyspnea, cough mainly dur-
ing the night and wheezing. Bronchoscopy showed no 
relapse; the general practitioner suspected a psychologi-
cal component due to the tracheal disease in conjunction 
with a recent bereavement. Since the symptoms did not 
stop in the following weeks, the patient was again sent 
to our outpatient clinic. At chest examination wheezing 
Fig. 1 Flow-volume curve during forced maneuvers. The plateau 
of both the inspiratory and expiratory phases shown during forced 
maneuvers is suggestive of fixed central or upper airway obstruction
Fig. 2 Inspective bronchoscopy revealing a subglottic tracheal 
stenosis
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was detected. Baseline spirometry showed an obstruc-
tive ventilatory defect of moderate severity (FEV1 1,48 
L, FVC 2,68 L, and FEV1/FVC 0.55 corresponding to 
61, 94 and 70% of the predicted value, respectively), 
with an improvement equal to 607  mL (25%) in terms 
of FEV1 after 400 mcg of inhaled albuterol via metered-
dose inhaler (MDI) (FEV1 post bronchodilation: 2,09 L, 
86% of predicted value). The suspicion of asthma was 
confirmed. The patient was prescribed fluticasone pro-
pionate and formoterol fumarate dihydrate at a dose of 
125/5 mcg twice daily via MDI. During the subsequent 
6  months of treatment she achieved normal lung func-
tion (FEV1 2,76 L, FVC 3,05 L, and FEV1/FVC 0.91 cor-
responding to 114, 107, and 115% of the predicted value, 
respectively) with well controlled respiratory symp-
toms, and no asthma exacerbations or relapses. Accord-
ingly, the inhalation therapy was down titrated to 50/5 
mcg twice daily, with clinical stability maintained at 
12 months of follow-up.
Discussion
Respiratory symptoms are common, may overlap and are 
rarely specific for the underlining disease. In this case 
report, the patient’s history at presentation did not fit 
entirely with the clinical picture of bronchial asthma, due 
to constant symptoms with no temporal fluctuations [7]. 
The lack of improvement with inhaled steroids, although 
usually very effective for control of symptoms, does not 
rule out the diagnosis of asthma, since failure to improve 
can result from several underlining factors, including lack 
of compliance or incorrect use of the inhalation device. 
Dyspnea on exertion as the main symptom requires the 
exclusion primarily of chronic obstructive pulmonary 
disease (COPD) and chronic heart failure. Cigarette 
smoke is a risk factor for both diseases; however the 
smoking history of the patient was mild (<10 pack/years), 
and the presence of inspiratory stridor at clinical exami-
nation reduced the clinical plausibility of COPD. On 
the other hand, chronic heart failure was unlikely to be 
present, since arterial hypertension was well controlled 
with therapy, and there was no history of decompensated 
heart failure, or evidence of either electrocardiographic 
or echocardiographic alteration.
Fixation error is common in medicine, and occurs when 
a physician concentrates on only one aspect of a clini-
cal case, without considering other relevant aspects [8], 
for example focusing on wheezing without recognizing 
stridor. In all chronic respiratory diseases the execution 
of lung function tests is of major importance to assess 
the presence, type and reversibility of a ventilator defect. 
If in some cases the test can confirm a diagnosis (e.g. in 
COPD), in others, such as in extra-thoracic airways 
obstruction, it may hint at the diagnostic pathway, e.g. sug-
gesting a possible narrowing which should be verified by 
other procedures such as endoscopy. In our case, spirom-
etry confirmed the most striking clinical information we 
obtained through the physical examination; stridor during 
forced inspiration, showing a fixed central or upper airway 
obstructive defect which is suspicious for the presence of 
laryngeal or tracheal stenosis. Notably, forced inspiratory 
and expiratory flow–volume curves should be repeatable 
and near maximal to assess these types of defects [4].
Despite the technological improvements and more 
skillful patient care in intensive care units, the most 
common benign cause of tracheal stenosis in the adult 
population is post-intubation laryngotracheal stenosis 
[9]. Our patient had a history of elective surgery (chol-
ecystectomy); however the latter was performed 5 years 
before, whilst stenosis after surgery usually develops in 2 
to 24 weeks after extubation [10]. Among rarer causes of 
tracheal lumen narrowing due to extrinsic compression 
are thyroid pathologies, vascular anomalies, or medias-
tinal lymphadenopathies, whilst intrinsic narrowing is 
more commonly a consequence of malignancy, tracheo-
malacia, granulomatosis with polyangiitis, or chronic 
inflammatory diseases (e.g., sarcoidosis).
Reported for the first time by Brandenburg in 1972, 
an idiopathic tracheal stenosis has to be suspected when 
an underlying etiology cannot be identified, as was the 
Fig. 3 Rigid bronchoscopy showing the upper tracheal circumferen-
tial stenosis. a Before procedure and b restored patency immediately 
after the procedure
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case for the patient of our report. This condition usually 
affects the upper trachea and occurs in the third to fifth 
decade of life, mostly in females [11–14]. Diagnosis of 
idiopathic tracheal stenosis may be difficult to achieve, 
and it is often made per exclusionem of other more com-
mon causes of dyspnea. In this case the suspicion should 
have been raised at physical examination, while spirom-
etry increased the suspicion. The classic spirometric 
defect, a reduction in the peak expiratory flow followed 
by a plateau, may be seen only if the tracheal diameter 
is reduced to 8–10 mm. A computed tomography scan 
usually provides precise information regarding extent 
and severity of the stenosis, but ultimately the mainstay 
of diagnosis is represented by bronchoscopy.
The treatment of tracheal stenosis varies with the 
type and extent of the disease [15]. The approach is 
preferably surgical, entailing a single-stage laryngotra-
cheal resection. In many cases, however, endoscopic 
management, laser bronchoscopy, endoscopic tracheal 
dilation, or stent placement is preferred [15]. In benign 
stenosis, a major factor for relapsing is a length of the 
stenosis >10 mm (15 mm in this case) [15]. Our patient 
was aware of the possibility of relapses, but decided for 
the less invasive bronchoscopic treatment.
Due to persistence and evolution of respiratory symp-
toms, once a relapse was excluded, the patient underwent 
a positive β2-stimulant reversibility test which clearly 
confirmed the suspicion of asthma. Although we cannot 
rule out that the patient was affected by asthma at the first 
respiratory evaluation, the clinical and functional find-
ings were dominated by the upper airway stenosis. After 
the diagnosis, in consideration of the obstructive ventila-
tory pattern and failure of the previous treatment regimen 
with low dose inhaled steroids, the patient was treated 
with the combination of fluticasone propionate and for-
moterol fumarate dehydrate at medium dosage, which 
provides a valid therapeutic option in terms of efficacy, 
patient adherence to treatment and compliance to the rec-
ommendations of international guidelines, and confirmed 
its efficacy and safety [16–18] in this indication.
A common misdiagnosis in patients with respiratory 
disease is depression and anxiety. Although depression 
may be more common in asthmatic patients, this diagno-
sis and other respiratory conditions should be carefully 
excluded before labeling the patient as “anxious” [19–21]. 
However, appropriate psychiatric referral should be pro-
posed if a psychiatric disease is suspected.
Conclusion and teaching points
Dyspnea and wheezing are frequently associated with 
asthma, a disease highly prevalent in the general pop-
ulation. Although it is known that other diseases may 
mimic asthma, their recognition may not be immediate 
and rarer conditions, such as tracheal stenosis, may be 
the cause or may overlap with asthma.
Pulmonary function tests should be performed 
according to ERS/ATS guidelines [4, 22] and represent 
the first test to perform in chronic respiratory condi-
tions to confirm a suspicion of asthma, COPD, or to 
suggest other diseases. Morphology of the inspiratory 
and expiratory flow-volume loop should be carefully 
inspected, since it may unveil extra-thoracic or central 
defects requiring specific evaluation, such as endo-
scopic exploration.
When assessing dyspnea, anxiety and/or depression 
should be diagnosed after careful exclusion of relevant 
respiratory and cardiovascular conditions.
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